Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $932.38 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $247.75 | 9 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $138.98 | 2 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $133.58 | 9 | $0 (2024) |
| Alkermes, Inc. | $112.06 | 5 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $103.77 | 4 | $0 (2024) |
| Lundbeck LLC | $67.16 | 3 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $32.10 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $31.85 | 1 | $0 (2024) |
| Braeburn Inc. | $28.77 | 1 | $0 (2024) |
| Boston Scientific Corporation | $18.23 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $774.12 | 34 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($247.75) |
| 2022 | $18.23 | 1 | Boston Scientific Corporation ($18.23) |
| 2017 | $140.03 | 2 | Otsuka America Pharmaceutical, Inc. ($121.90) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: Neuropsychiatry | ||||||
| 12/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: Neuropsychiatry | ||||||
| 12/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: CNS | ||||||
| 12/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: Neuropsychiatry | ||||||
| 11/08/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Neurology | ||||||
| 10/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: Neuropsychiatry | ||||||
| 10/29/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Neurology | ||||||
| 10/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.34 | General |
| Category: Neuropsychiatry | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Neuropsychiatry | ||||||
| 10/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.28 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: CNS | ||||||
| 09/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.94 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: CNS | ||||||
| 08/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: PSYCHIATRY | ||||||
| 08/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: CNS | ||||||
| 07/27/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Neuropsychiatry | ||||||
| 07/27/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $3.25 | General |
| Category: Neuropsychiatry | ||||||
About Dr. Claudio Cabrejos, MD
Dr. Claudio Cabrejos, MD is a Psychiatry healthcare provider based in San Marcos, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033133483.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Claudio Cabrejos, MD has received a total of $932.38 in payments from pharmaceutical and medical device companies, with $774.12 received in 2024. These payments were reported across 37 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($932.38).
Practice Information
- Specialty Psychiatry
- Location San Marcos, CA
- Active Since 07/27/2006
- Last Updated 05/16/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1033133483
Products in Payments
- CAPLYTA (Drug) $247.75
- INGREZZA (Drug) $133.58
- ABILIFY MAINTENA (Drug) $121.90
- UZEDY (Drug) $103.77
- ARISTADA (Drug) $89.09
- REXULTI (Drug) $67.16
- HETLIOZ (Drug) $32.10
- SPRAVATO (Drug) $31.85
- BRIXADI (Drug) $28.77
- VIVITROL (Drug) $22.97
- LUX-Dx Insertable Cardiac Monitor (Device) $18.23
- PREZCOBIX (Drug) $18.13
- ABILIFY ASIMTUFII (Drug) $17.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in San Marcos
Dr. Alan Berkowitz, Md, MD
Psychiatry — Payments: $13,876
Sheila Cai, Md, MD
Psychiatry — Payments: $6,705
Dr. Paul Whitelock, M.d, M.D
Psychiatry — Payments: $5,389
Dr. Josefa Licas, M.d, M.D
Psychiatry — Payments: $5,218
Dr. Garrick Tong, M.d, M.D
Psychiatry — Payments: $2,948
Mr. Arvin Mirow, Md, MD
Psychiatry — Payments: $2,734